Literature DB >> 30105802

Proteomics: Clinical and research applications in respiratory diseases.

Katy C Norman1, Bethany B Moore2,3, Kelly B Arnold1, David N O'Dwyer2.   

Abstract

The proteome is the study of the protein content of a definable component of an organism in biology. However, the tissue-specific expression of proteins and the varied post-translational modifications, splice variants and protein-protein complexes that may form, make the study of protein a challenging yet vital tool in answering many of the unanswered questions in medicine and biology to date. Indeed, the spatial, temporal and functional composition of proteins in the human body has proven difficult to elucidate for many years. Given the effect of microRNA and epigenetic regulation on silencing and enhancing gene transcription, the study of protein arguably provides more accurate information on homeostasis and perturbation in health and disease. There have been significant advances in the field of proteomics in recent years, with new technologies and platforms available to the research community. In this review, we briefly discuss some of these new technologies and developments in the context of respiratory disease. We also discuss the types of data science approaches to analyses and interpretation of the large volumes of data generated in proteomic studies. We discuss the application of these technologies with regard to respiratory disease and highlight the potential for proteomics in generating major advances in the understanding of respiratory pathophysiology into the future.
© 2018 Asian Pacific Society of Respirology.

Entities:  

Keywords:  application; clinical; lung disease; proteomics; research

Mesh:

Year:  2018        PMID: 30105802      PMCID: PMC6234509          DOI: 10.1111/resp.13383

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  85 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  High-throughput mass spectrometric discovery of protein post-translational modifications.

Authors:  M R Wilkins; E Gasteiger; A A Gooley; B R Herbert; M P Molloy; P A Binz; K Ou; J C Sanchez; A Bairoch; K L Williams; D F Hochstrasser
Journal:  J Mol Biol       Date:  1999-06-11       Impact factor: 5.469

Review 3.  Application of proteomics in biomarker discovery: a primer for the clinician.

Authors:  V Tambor; A Fucíková; J Lenco; M Kacerovský; V Rehácek; J Stulík; R Pudil
Journal:  Physiol Res       Date:  2009-11-20       Impact factor: 1.881

4.  Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways.

Authors:  L M Teran; N Noso; M Carroll; D E Davies; S Holgate; J M Schröder
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

5.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

Review 6.  Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.

Authors:  David N O'Dwyer; Shanna L Ashley; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

7.  Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy.

Authors:  Francesco S Loffredo; Matthew L Steinhauser; Steven M Jay; Joseph Gannon; James R Pancoast; Pratyusha Yalamanchi; Manisha Sinha; Claudia Dall'Osso; Danika Khong; Jennifer L Shadrach; Christine M Miller; Britta S Singer; Alex Stewart; Nikolaos Psychogios; Robert E Gerszten; Adam J Hartigan; Mi-Jeong Kim; Thomas Serwold; Amy J Wagers; Richard T Lee
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

8.  Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database.

Authors:  George A Khoury; Richard C Baliban; Christodoulos A Floudas
Journal:  Sci Rep       Date:  2011-09-13       Impact factor: 4.379

9.  Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.

Authors:  Kelly D Sullivan; Donald Evans; Ahwan Pandey; Thomas H Hraha; Keith P Smith; Neil Markham; Angela L Rachubinski; Kristine Wolter-Warmerdam; Francis Hickey; Joaquin M Espinosa; Thomas Blumenthal
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

10.  Structural basis for IL-1α recognition by a modified DNA aptamer that specifically inhibits IL-1α signaling.

Authors:  Xiaoming Ren; Amy D Gelinas; Ira von Carlowitz; Nebojsa Janjic; Anna Marie Pyle
Journal:  Nat Commun       Date:  2017-10-09       Impact factor: 14.919

View more
  9 in total

Review 1.  Sample Multiplexing Strategies in Quantitative Proteomics.

Authors:  Albert B Arul; Renã A S Robinson
Journal:  Anal Chem       Date:  2018-12-18       Impact factor: 6.986

2.  Proteomic Analysis Reveals Differential Expression Profiles in Idiopathic Pulmonary Fibrosis Cell Lines.

Authors:  Juan Manuel Velázquez-Enríquez; Alma Aurora Ramírez-Hernández; Luis Manuel Sánchez Navarro; Itayetzi Reyes-Avendaño; Karina González-García; Cristian Jiménez-Martínez; Luis Castro-Sánchez; Xariss Miryam Sánchez-Chino; Verónica Rocío Vásquez-Garzón; Rafael Baltiérrez-Hoyos
Journal:  Int J Mol Sci       Date:  2022-05-01       Impact factor: 6.208

3.  Calprotectin, an available prognostic biomarker in systemic sclerosis: a systematic review.

Authors:  Bahareh Ebrahimi; MohamadAli Nazarinia; Mina Molayem
Journal:  Clin Rheumatol       Date:  2020-10-12       Impact factor: 2.980

4.  Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.

Authors:  Jamie L Todd; Megan L Neely; Robert Overton; Katey Durham; Mridu Gulati; Howard Huang; Jesse Roman; L Kristin Newby; Kevin R Flaherty; Richard Vinisko; Yi Liu; Janine Roy; Ramona Schmid; Benjamin Strobel; Christian Hesslinger; Thomas B Leonard; Imre Noth; John A Belperio; Scott M Palmer
Journal:  Respir Res       Date:  2019-10-22

Review 5.  Non-targeted proteomics of acute respiratory distress syndrome: clinical and research applications.

Authors:  Xu-Peng Wen; Yue-Zhong Zhang; Qi-Quan Wan
Journal:  Proteome Sci       Date:  2021-03-20       Impact factor: 2.480

6.  Fibromine is a multi-omics database and mining tool for target discovery in pulmonary fibrosis.

Authors:  Dionysios Fanidis; Panagiotis Moulos; Vassilis Aidinis
Journal:  Sci Rep       Date:  2021-11-05       Impact factor: 4.379

7.  Large-scale plasma proteomics can reveal distinct endotypes in chronic obstructive pulmonary disease and severe asthma.

Authors:  Masaru Suzuki; John J Cole; Satoshi Konno; Hironi Makita; Hiroki Kimura; Masaharu Nishimura; Rose A Maciewicz
Journal:  Clin Transl Allergy       Date:  2021-12       Impact factor: 5.871

8.  Dynamic Urinary Proteome Changes in Ovalbumin-Induced Asthma Mouse Model Using Data-Independent Acquisition Proteomics.

Authors:  Weiwei Qin; Ting Wang; Guangwei Liu; Lixin Sun; Wei Han; Youhe Gao
Journal:  J Asthma Allergy       Date:  2021-11-09

9.  Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis.

Authors:  Yasushi Horimasu; Kakuhiro Yamaguchi; Shinjiro Sakamoto; Takeshi Masuda; Shintaro Miyamoto; Taku Nakashima; Hiroshi Iwamoto; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori
Journal:  Orphanet J Rare Dis       Date:  2021-07-03       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.